Ginkgo biloba 500 mg
On sale on the US market (according to the DSLD)
Bronson, food supplement from the US market
Ginkgo biloba 500 mg (Bronson), a food supplement without a usable barcode in DSLD, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Bronson
- Barcode
- Not provided or invalid in DSLD
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Modified Cellulose, Magnesium Stearate, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Ginkgo biloba, Powder | Plant | 500 mg |
| Ginkgo biloba Leaf extract | Plant | 125 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Ginkgo Biloba 500 mg
Entered into DSLD on 22 August 2024. On sale on the US market (according to the DSLD).Same active composition.
Official label: Ginkgo Biloba 500 mg
Entered into DSLD on 24 October 2023. Withdrawn from the US market on 27 March 2025 (according to the DSLD).- Active ingredient removed : Ginkgo biloba Leaf extract (125 mg)
Official label: Ginkgo Biloba 500 mg
Entered into DSLD on 24 May 2023. Withdrawn from the US market on 4 August 2023 (according to the DSLD).- Same quantity, different name: Ginkgo, Powder in this version; Ginkgo biloba, Powder on the displayed label (500 mg)
Official label: Ginkgo Biloba 500 mg
Entered into DSLD on 19 November 2021. Withdrawn from the US market on 28 February 2023 (according to the DSLD).- Active ingredient removed : Ginkgo biloba Leaf extract (125 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Bronson
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Ginkgo biloba 500 mg (Bronson): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/dsld-336623-ginkgo-biloba-500-mg-bronson, updated 22 August 2025.